GenWorks Health launches IVD tests for dengue and malaria
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
Rapid card test kits for iScreen malaria card antigen (Pf/Pv) & iScreen dengue NS1
GenWorks has scaled up its e-commerce platform in terms of building traffic
Laurus will also provide funding for the clinical trials and will launch these products in India and emerging markets
Urges Innovators to produce quality products that can be deployed at scale
Collaboration to accelerate and de-risk clinical development of Nanopharmaceutics CNS portfolio
Investment enables development of revolutionary multi-omic platform using super-resolution imaging technology for earlier disease detection and accelerated discovery of therapeutics
Launched Pathology Laboratory in Vijayawada offering a wide range of best-in-class diagnostic services with over 2500+ tests
Olverembatinib is the first and only third-generation BCR-ABL inhibitor approved in China for the treatment of adult patients with tyrosine kinase inhibitors
Subscribe To Our Newsletter & Stay Updated